Prednisolone Sodium Phosphate Solution
NDC Package 70518-4524-2
Package Information
Prednisolone Sodium Phosphate solution is prednisolone is a man-made form of a natural substance (corticosteroid hormone) made by the adrenal gland. This formulation utilizes a solution delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4524 and is authorized under FDA application ANDA076913.
Identification & Billing
- RxCUI: 283077 - prednisoLONE sodium phosphate 15 MG in 5 mL Oral Solution
- RxCUI: 283077 - prednisolone 3 MG/ML Oral Solution
- RxCUI: 283077 - prednisolone 15 MG (as prednisolone sodium phosphate 20.2 MG) per 5 ML Oral Solution
- RxCUI: 283077 - prednisolone 15 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70518 - Remedyrepack Inc.
- 70518-4524 - Prednisolone Sodium Phosphate
- 70518-4524-2 - 5 CUP in 1 BOX / 10 mL in 1 CUP (70518-4524-3)
- 70518-4524 - Prednisolone Sodium Phosphate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70518-4524). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70518-4524-2 identifies a specific commercial package of 5 cup in 1 box / 10 ml in 1 cup (70518-4524-3) of Prednisolone Sodium Phosphate, a human prescription drug labeled by Remedyrepack Inc.. This solution is formulated for oral use and contains prednisolone sodium phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on November 28, 2025. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Prednisolone is a man-made form of a natural substance (corticosteroid hormone) made by the adrenal gland. It is used to treat conditions such as arthritis, blood problems, immune system disorders, skin and eye conditions, breathing problems, cancer, and severe allergies. It decreases your immune system's response to various diseases to reduce symptoms such as pain, swelling and allergic-type reactions.
How is this Remedyrepack Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518452402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.